NCT00265733View on ClinicalTrials.gov

Paclitaxel Poliglumex and Capecitabine in Treating Patients With Metastatic Breast Cancer

PHASE2CompletedINTERVENTIONAL
Enrollment

48

Participants

Timeline

Start Date

February 28, 2006

Primary Completion Date

August 31, 2007

Study Completion Date

May 31, 2013

Conditions
Breast Cancer
Interventions
DRUG

capecitabine

DRUG

paclitaxel poliglumex

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Alliance for Clinical Trials in Oncology

OTHER

NCT00265733 - Paclitaxel Poliglumex and Capecitabine in Treating Patients With Metastatic Breast Cancer | Biotech Hunter | Biotech Hunter